道琼斯指数
52,342.56
涨跌
-132.54-0.25%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 -0.25%,标普 500 指数为 -0.30%,纳斯达克综合指数为 -1.38%。个股方面,2,629 只上涨、2,487 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc.AMGN | $460.67 | +1.94% | 1.83M | $249.05B | $288.00 - $469.03 | 0.02% |
| 2 | Gilead Sciences Inc.GILD | $165.44 | +4.01% | 6.10M | $205.13B | $114.02 - $165.51 | 0.02% |
| 3 | Moderna, Inc.MRNA | $222.72 | +4.00% | 9.96M | $88.92B | $22.28 - $254.48 | 0.00% |
| 4 | IQVIA Holdings Inc.IQV | $274.97 | -1.66% | 1.14M | $45.26B | $154.50 - $286.37 | 0.00% |
| 5 | Revolution Medicines, Inc.RVMD | $190.30 | +0.91% | 890.66K | $40.79B | $56.66 - $224.31 | 0.00% |
| 6 | Biogen Inc.BIIB | $249.72 | +2.35% | 891.46K | $36.90B | $138.00 - $258.78 | 0.00% |
| 7 | Incyte Genomics Inc.INCY | $116.77 | -0.09% | 2.51M | $23.67B | $88.20 - $132.60 | 0.00% |
| 8 | Medpace Holdings, Inc.MEDP | $677.63 | -2.22% | 195.95K | $18.95B | $373.00 - $709.00 | 0.00% |
| 9 | Charles River Laboratories International, Inc.CRL | $376.07 | +0.57% | 696.41K | $17.95B | $146.19 - $381.49 | 0.00% |
| 10 | Exelixis Inc.EXEL | $66.26 | -1.00% | 2.37M | $16.42B | $36.00 - $67.44 | 0.00% |
| 11 | Neurocrine Biosciences Inc.NBIX | $146.46 | +0.62% | 663.67K | $14.89B | $122.14 - $186.12 | 0.00% |
| 12 | Halozyme Therapeutics, Inc.HALO | $131.13 | +0.85% | 1.21M | $14.88B | $61.23 - $132.83 | 0.00% |
| 13 | Bio-Techne Corp.TECH | $72.72 | +0.03% | 2.16M | $11.40B | $43.20 - $73.14 | 0.00% |
| 14 | Twist Bioscience CorporationTWST | $173.56 | +0.07% | 1.59M | $10.88B | $23.30 - $219.71 | 0.00% |
| 15 | Repligen Corp.RGEN | $188.57 | +2.10% | 760.52K | $10.64B | $100.99 - $198.87 | 0.00% |
| 16 | Kymera Therapeutics, Inc.KYMR | $122.60 | +0.04% | 904.54K | $10.19B | $55.66 - $130.05 | 0.00% |
| 17 | Krystal Biotech, Inc.KRYS | $324.13 | +0.90% | 131.49K | $9.59B | $183.26 - $382.54 | 0.00% |
| 18 | Vaxcyte, Inc.PCVX | $62.63 | +1.90% | 1.63M | $9.32B | $39.87 - $90.75 | 0.00% |
| 19 | ImmunityBio, Inc.IBRX | $8.73 | -0.91% | 6.36M | $9.26B | $1.95 - $12.43 | 0.00% |
| 20 | Kodiak Sciences Inc.KOD | $100.46 | +3.32% | 1.07M | $6.31B | $15.83 - $104.00 | 0.00% |
| 21 | Immunovant, Inc.IMVT | $29.63 | +0.68% | 1.23M | $6.12B | $21.34 - $45.42 | 0.00% |
| 22 | CG Oncology, Inc.CGON | $63.43 | -0.86% | 277.20K | $5.62B | $35.80 - $80.97 | 0.00% |
| 23 | Scholar Rock Holding CorporationSRRK | $44.17 | +2.06% | 911.61K | $5.38B | $27.07 - $61.76 | 0.00% |
| 24 | CRISPR Therapeutics AGCRSP | $54.24 | +0.29% | 1.03M | $5.24B | $44.12 - $65.98 | 0.00% |
| 25 | Adaptive Biotechnologies CorporationADPT | $28.17 | -0.67% | 2.00M | $4.50B | $12.00 - $30.74 | 0.00% |
| 26 | Iovance Biotherapeutics, Inc.IOVA | $9.55 | -35.58% | 56.96M | $4.32B | $1.76 - $17.07 | 0.00% |
| 27 | Relay Therapeutics, Inc.RLAY | $19.46 | -1.12% | 1.67M | $4.26B | $5.95 - $21.27 | 0.00% |
| 28 | Tarsus Pharmaceuticals, Inc.TARS | $74.13 | +2.93% | 338.71K | $3.65B | $53.89 - $91.53 | 0.00% |
| 29 | Denali Therapeutics Inc.DNLI | $19.34 | +0.26% | 1.14M | $3.09B | $13.75 - $27.30 | 0.00% |
| 30 | Beam Therapeutics Inc.BEAM | $28.84 | +0.21% | 1.70M | $2.98B | $20.23 - $38.26 | 0.00% |
| 31 | ADMA Biologics, Inc.ADMA | $11.75 | +4.17% | 2.36M | $2.63B | $7.21 - $20.46 | 0.00% |
| 32 | Recursion Pharmaceuticals, Inc.RXRX | $4.24 | -2.53% | 19.53M | $2.27B | $2.77 - $6.10 | 0.00% |
| 33 | Vericel CorporationVCEL | $42.90 | +4.36% | 405.10K | $2.20B | $28.95 - $49.32 | 0.00% |
| 34 | BioCryst Pharmaceuticals Inc.BCRX | $8.53 | +1.91% | 2.16M | $2.18B | $6.23 - $11.22 | 0.00% |
| 35 | Absci CorporationABSI | $12.10 | +1.85% | 3.89M | $2.08B | $2.24 - $12.52 | 0.00% |
| 36 | Vir Biotechnology, Inc.VIR | $11.75 | -1.51% | 1.14M | $1.99B | $4.82 - $12.18 | 0.00% |
| 37 | Novavax Inc.NVAX | $10.46 | +1.36% | 2.37M | $1.73B | $6.20 - $13.38 | 0.00% |
| 38 | Maze Therapeutics, Inc.MAZE | $31.91 | +0.63% | 366.16K | $1.73B | $21.95 - $53.65 | 0.00% |
| 39 | Hemab Therapeutics Holdings, Inc.COAG | $40.47 | +4.99% | 1.14M | $1.68B | $23.00 - $55.42 | 0.00% |
| 40 | Replimune Group, Inc.REPL | $17.39 | +8.28% | 4.78M | $1.63B | $1.50 - $17.75 | 0.00% |
| 41 | Taysha Gene Therapies, Inc.TSHA | $4.22 | -0.24% | 1.47M | $1.38B | $3.46 - $7.30 | 0.00% |
| 42 | Vor Biopharma Inc.VOR | $20.91 | +1.26% | 887.09K | $1.24B | $6.50 - $26.80 | 0.00% |
| 43 | Inhibrx Biosciences, Inc.INBX | $73.57 | +0.21% | 327.62K | $1.08B | $57.30 - $155.29 | 0.00% |
| 44 | Cullinan Therapeutics, Inc.CGEM | $15.45 | -0.74% | 344.69K | $994.28M | $6.73 - $23.19 | 0.00% |
| 45 | Prime Medicine, Inc.PRME | $5.22 | -2.24% | 9.62M | $947.69M | $2.67 - $5.90 | 0.00% |
| 46 | MeiraGTx Holdings plcMGTX | $9.71 | -0.46% | 366.71K | $932.39M | $6.62 - $15.35 | 0.00% |
| 47 | Odyssey Therapeutics, Inc.ODTX | $19.81 | +1.33% | 186.83K | $927.53M | $15.10 - $29.05 | 0.00% |
| 48 | Monte Rosa Therapeutics, Inc.GLUE | $10.87 | +0.32% | 917.08K | $927.19M | $9.68 - $25.77 | 0.00% |
| 49 | Sana Biotechnology, Inc.SANA | $2.73 | +3.61% | 2.92M | $815.76M | $2.22 - $5.58 | 0.00% |
| 50 | OmniAb, Inc.OABI | $5.24 | -0.76% | 1.56M | $758.93M | $1.30 - $5.43 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。